Goodwin Procter advised HOOKIPA, and Duane Morris advised the underwriters involved in the offering. HOOKIPA Pharma Inc. (Nasdaq: HOOK) announced its underwritten public offering of 22,900,768...
HOOKIPA Pharma’s $50 Million Public Offering of Common Stock and Convertible Preferred Stock
Genfit’s Acquisition of Versantis
VISCHER AG advised Versantis with Mark Fitzpatrick as CEO, Vincent Forster as CSO and Meriam Kabbaj as COO. Goodwin advised the sellers. Linklaters and Niederer Kraft...
Scholar Rock Holding Corporation’s $205 Million Shares Offering
Goodwin Procter advised Scholar Rock Holding Corporation on the deal. Scholar Rock Holding Corporation announced the completion of its registered direct offering of 16,326,530 shares of common...
Regeneron Pharmaceuticals’ Acquisition of Checkmate Pharmaceuticals
Wachtell, Lipton, Rosen & Katz advised Regeneron on the deal, while Goodwin represented Checkmate Pharmaceuticals. Fried Frank acted as counsel to Centerview Partners, financial advisor to...
Janssen Pharmaceuticals’ Acquisition of Anakuria Therapeutics
Goodwin Procter advised Navitor Pharmaceuticals on the deal. Privately held Navitor Pharmaceuticals, LLC (“Navitor”), announced that Janssen Pharmaceuticals, Inc. (“Janssen”), one of the Janssen Pharmaceutical Companies...
Adient’s $1 Billion Amended Credit Facility
Cahill represented the administrative agent and lead arrangers in the deal. Adient US LLC and Adient Global Holdings S.à r.l. entered into an amendment of the Term...
Iridium Satellite’s $1.64 Billion Credit Facility
Cahill represented the lead arrangers in the transaction. The transaction consisted in a repricing of the $1,637,625,000 term B credit facility for Iridium Satellite LLC, a subsidiary...